Foley & Lardner LLP represented Health Care Service Corporation (HCSC) on the deal, while Latham & Watkins LLP represented Trustmark in the transaction. Health Care Service Corporation...
You must be a Standard 1 Year member to access this content.
Bär & Karrer and Latham & Watkins advised Archroma in this transaction. Archroma, a portfolio company of SK Capital Partners, has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Noerr and King & Spalding advised Circular Resources on the deal, while Latham & Watkins advised H.I.G. Capital. Circular Resources, a plastic waste recycling company, announced...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters, led by BofA Securities, Inc., J.P. Morgan Securities LLC, MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, in the offering....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Evertec, while Simpson Thacher represented the underwriters, led by J.P. Morgan Securities in the offering. Popular, Inc. (the “Selling Stockholder”) announced the secondary offering...
You must be a Standard 1 Year member to access this content.
Walkers and Latham & Watkins advised Fullerton Healthcare on its recapitalization by RRJ Capital, assisted by White & Case LLP. BofA Securities acted as the sole...
You must be a Standard 1 Year member to access this content.
Freshfields advised UPS on the deal. Latham & Watkins assisted Archimed. Simmons & Simmons acted for Marco Ruini , CEO of Bomi Group. UPS (NYSE: UPS)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Gonzalez Calvillo advised the Sculptor Capital Management, Inc. on the transaction. Greenberg Traurig advised The Dolphin Company. Akin Gump Strauss Hauer &...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented Pfizer, while Cravath, Swaine & Moore and Goodwin Procter represented Global Blood Therapeutics in the transaction. Latham & Watkins represented the...
You must be a Standard 1 Year member to access this content.
White & Case represented Colonnade, while Latham & Watkins represented Plastiq in the transaction. Colonnade Acquisition Corp. II, a special purpose acquisition company (NYSE: CLAA), announced...
You must be a Standard 1 Year member to access this content.
Withers advised Molten Ventures on the deal, while Latham & Watkins advised Altruistiq. Molten Ventures acted as lead investor in the £15 million seed round of...
You must be a Standard 1 Year member to access this content.
